Free Trial
OTCMKTS:EDTXF

Spectral Diagnostics (EDTXF) Stock Price, News & Analysis

Spectral Diagnostics logo
$0.61 +0.01 (+2.24%)
As of 06/27/2025 12:14 PM Eastern

About Spectral Diagnostics Stock (OTCMKTS:EDTXF)

Key Stats

Today's Range
$0.61
$0.61
50-Day Range
$0.56
$0.65
52-Week Range
$0.32
$0.65
Volume
334 shs
Average Volume
6,370 shs
Market Capitalization
$174.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Spectral Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

EDTXF MarketRank™: 

Spectral Diagnostics scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Spectral Diagnostics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Spectral Diagnostics is -8.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Spectral Diagnostics is -8.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Spectral Diagnostics' valuation and earnings.
  • Percentage of Shares Shorted

    0.03% of the float of Spectral Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Spectral Diagnostics has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Spectral Diagnostics has recently decreased by 14.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Spectral Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Spectral Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.03% of the float of Spectral Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Spectral Diagnostics has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Spectral Diagnostics has recently decreased by 14.24%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Spectral Diagnostics has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
Receive EDTXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

EDTXF Stock News Headlines

Trump Knows Exactly What He’s Doing…
With Trump in office, new money is flowing in and out of the market like never before... And some folks using my strategy are making a fast fortune... no matter which way the market moves. This is the same one-ticker strategy I used to make more $95 million in verified profits for my clients during the 2008 financial crisis. But now... with Trump sending about $240 billon into the markets every week on specific, pre-determined dates...
Spectral Medical Inc. (EDTXF)
See More Headlines

EDTXF Stock Analysis - Frequently Asked Questions

Spectral Diagnostics' stock was trading at $0.3474 at the beginning of the year. Since then, EDTXF stock has increased by 75.7% and is now trading at $0.6103.
View the best growth stocks for 2025 here
.

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) announced its earnings results on Friday, May, 9th. The company reported ($0.03) EPS for the quarter. The company had revenue of $0.40 million for the quarter.

Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/09/2025
Today
6/28/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
N/A
Current Symbol
OTCMKTS:EDTXF
Previous Symbol
OTCMKTS:DIAGF
CIK
N/A
Employees
29
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.24 million
Net Margins
-1,078.10%
Pretax Margin
-1,077.59%

Debt

Sales & Book Value

Annual Sales
$1.67 million
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-8.72

Miscellaneous

Free Float
281,237,000
Market Cap
$174.25 million
Optionable
Not Optionable
Beta
0.23

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:EDTXF) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners